Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.56 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 6/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | PRKCA | P17252 | 2/20 | 0.43 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.40 |
| ▸ | GLS2 | Q9UI32 | 2/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28023394 | 0.93 | CA1 (0.53) | ZDHHC7ABCB1CA1CA2FAAH | |
| SCHEMBL28899611 | 0.91 | ZDHHC7 (0.47) | ZDHHC7FAAHPRKCA | |
| SCHEMBL29236312 | 0.91 | ZDHHC7 (0.47) | ZDHHC7FAAHPRKCA | |
| SCHEMBL15945448 | 0.85 | CA1 (0.42) | ZDHHC7ABCB1CA1CA2LMNA | |
| SCHEMBL7150988 | 0.84 | ALDH1A1 (0.42) | ZDHHC7ABCB1CA1CA2LMNA | |
| SCHEMBL8380705 | 0.84 | TSHR (0.47) | ZDHHC7FAAHLMNAPRKCA | |
| SCHEMBL6258273 | 0.84 | TSHR (0.47) | ZDHHC7FAAHLMNAPRKCA | |
| SCHEMBL11838076 | 0.84 | ZDHHC7 (0.54) | ZDHHC7ABCB1CA1CA2FAAH | |
| SCHEMBL8376617 | 0.84 | TSHR (0.47) | ZDHHC7FAAHLMNAPRKCA | |
| SCHEMBL10890705 | 0.84 | FAAH (0.44) | ZDHHC7ABCB1FAAHLMNAPRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7101831-B2 | Compositions of material, especially lubricants and pressure transmitting means, the production and use thereof | FUCHS PETROLUB AG (DE) | 2006-09-05 | — | — | US | disclosed |
| US-20030186823-A1 | Novel compositions of material, especially lubricants and pressure transmitting means, the production and use thereof | FUCHS PETROLUB SE (DE) | 2003-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030186823-A1 | Novel compositions of material, especially lubricants and pressure transmitting means, the production and use thereof | SLC27A2, SLC27A1, ELOVL1 | ZDHHC7 245/4885ABCB1 3294/4885CA1 731/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.